Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...

Masimo’s revolutionary SET® pulse oximetry has been shown in more than 100 independent and objective studies to outperform other pulse oximetry technologies – even before the revisions that achieved ...

Masimo Corporation MASI received the FDA’s nod for its RD SET sensors to be used with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry. The procedure is aimed at offering improved ...

New Neonatal Study Adds to Body of Clinical Evidence Demonstrating Masimo SET ® Pulse Oximetry’s Unique Ability to Improve Care NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) provides ...

Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on ...

The TCM5 FLEX transcutaneous monitor is a compact, easy-to-use solution that delivers accurate and continuous measurement of oxygenation (tcpO2) and ventilation (tcpCO2) status in neonatal, pediatric ...

Pulse oximetry is a simple, noninvasive, painless test that can detect mild hypoxemia, a feature of many forms of CCHD that is easy to miss on physical examination. 5 As an adjunct to the standard ...

In the wake of the HHS Secretary’s recommendation that screening for CCHDs be added to RUSP for newborns, it is the responsibility of individual states to implement screening programs through ...